Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Pneumonia in children: Epidemiology, pathogenesis, and etiology

William J Barson, MD
Section Editor
Sheldon L Kaplan, MD
Deputy Editor
Mary M Torchia, MD


Childhood pneumonia is an important cause of morbidity in the developed world, and morbidity and mortality in the developing world. The epidemiology, microbiology, and pathogenesis of pneumonia in children will be reviewed here. The clinical features, diagnosis, and treatment of pneumonia in children are discussed separately, as is pneumonia in neonates (<28 days of age). (See "Community-acquired pneumonia in children: Clinical features and diagnosis" and "Community-acquired pneumonia in children: Outpatient treatment" and "Pneumonia in children: Inpatient treatment" and "Neonatal pneumonia".)


The terms pneumonia and pneumonitis strictly represent any inflammatory condition involving the lungs, which include the visceral pleura, connective tissue, airways, alveoli, and vascular structures. Lower respiratory tract infection (LRTI) is frequently used interchangeably to include bronchitis, bronchiolitis, and pneumonia, or any combination of the three. For the purposes of this review, pneumonia will be defined as a condition typically associated with fever, respiratory symptoms, and evidence of parenchymal involvement, either by physical examination or the presence of infiltrates on chest radiography. Bronchiolitis is discussed separately. (See "Bronchiolitis in infants and children: Clinical features and diagnosis", section on 'Clinical features'.)


Incidence — The World Health Organization (WHO) estimates there are 156 million cases of pneumonia each year in children younger than five years, with as many as 20 million cases severe enough to require hospital admission [1]. In the developed world, the annual incidence of pneumonia is estimated to be 33 per 10,000 in children younger than five years and 14.5 per 10,000 in children 0 to 16 years [2].

Approximately one-half of children younger than five years of age with community-acquired pneumonia (CAP) require hospitalization [3]. Hospitalization rates for pneumonia (all causes) among children younger than two years in the United States decreased after introduction of the pneumococcal conjugate vaccine to the routine childhood immunization schedule in 2000 (from 12 to 14 per 1000 population to 8 to 10 per 1000 population) (figure 1) [4].

Mortality — The mortality rate in developed countries is low (<1 per 1000 per year) [5,6]. In developing countries, respiratory tract infections are not only more prevalent but more severe. Worldwide, lower respiratory tract infections accounted for nearly 800,000 deaths among children ≤19 years in 2015 (31.1 per 100,000 population), second only to neonatal/preterm birth complications [7].

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 24, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008; 86:408.
  2. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011; 66 Suppl 2:ii1.
  3. Margolis P, Gadomski A. The rational clinical examination. Does this infant have pneumonia? JAMA 1998; 279:308.
  4. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:1.
  5. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137:977.
  6. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372:835.
  7. Global Burden of Disease Child and Adolescent Health Collaboration, Kassebaum N, Kyu HH, et al. Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study. JAMA Pediatr 2017; 171:573.
  8. Glezen P, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288:498.
  9. Pelton SI, Hammerschlag MR. Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children. Clin Pediatr (Phila) 2005; 44:1.
  10. Green GM, Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med 1967; 276:421.
  11. MacGregor RR. Alcohol and immune defense. JAMA 1986; 256:1474.
  12. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004; 113:443.
  13. Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369:1179.
  14. Griffin MR, Zhu Y, Moore MR, et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155.
  15. Griffin MR, Mitchel E, Moore MR, et al. Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012. MMWR Morb Mortal Wkly Rep 2014; 63:995.
  16. Zhou F, Kyaw MH, Shefer A, et al. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med 2007; 161:1162.
  17. Kronman MP, Hersh AL, Feng R, et al. Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007. Pediatrics 2011; 127:411.
  18. Resti M, Moriondo M, Cortimiglia M, et al. Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples. Clin Infect Dis 2010; 51:1042.
  19. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011; 30:289.
  20. Olarte L, Barson WJ, Barson RM, et al. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis 2017; 64:1699.
  21. Madhi SA, Klugman KP, Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10:811.
  22. Mani CS, Murray DL. Acute pneumonia and its complications. In: Principles and Practice of Pediatric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, Edinburgh 2012. p.235.
  23. Aherne W, Bird T, Court SD, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23:7.
  24. Lemaître C, Angoulvant F, Gabor F, et al. Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center. Pediatr Infect Dis J 2013; 32:1146.
  25. Baltimore RS. Pneumonia. In: Pediatric Infectious Diseases: Principles and Practice, 2nd ed, Jenson HB, Baltimore RS (Eds), WB Saunders, Philadelphia 2002. p.794.
  26. Byington CL, Bradley JS. Pediatric community-acquired pneumonia. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 7th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2014. p.283.
  27. Dakhama A, Lee YM, Gelfand EW. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J 2005; 24:S159.
  28. Mikami R, Murao M, Cugell DW, et al. International Symposium on Lung Sounds. Synopsis of proceedings. Chest 1987; 92:342.
  29. Health Policy and Clinical Effectiveness Department. Cincinnati Children's Hospital Medical Center. Community acquired pneumonia. www.cincinnatichildrens.org/svc/alpha/h/health-policy/ev-based/pneumonia.htm (Accessed on August 11, 2011).
  30. Isaacs D. Problems in determining the etiology of community-acquired childhood pneumonia. Pediatr Infect Dis J 1989; 8:143.
  31. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999; 18:98.
  32. Korppi M, Heiskanen-Kosma T, Jalonen E, et al. Aetiology of community-acquired pneumonia in children treated in hospital. Eur J Pediatr 1993; 152:24.
  33. Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J 1989; 8:856.
  34. Ruuskanen O, Nohynek H, Ziegler T, et al. Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis 1992; 11:217.
  35. Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis 1997; 16:388.
  36. Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998; 17:986.
  37. Numazaki K, Chiba S, Umetsu M, et al. Etiological agents of lower respiratory tract infections in Japanese children. In Vivo 2004; 18:67.
  38. Turner RB, Lande AE, Chase P, et al. Pneumonia in pediatric outpatients: cause and clinical manifestations. J Pediatr 1987; 111:194.
  39. Vuori E, Peltola H, Kallio MJ, et al. Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. SE-TU Study Group. Clin Infect Dis 1998; 27:566.
  40. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113:701.
  41. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 2009; 168:1429.
  42. Bradley JS. Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines. Pediatr Infect Dis J 2002; 21:592.
  43. Heiskanen-Kosma T, Korppi M, Leinonen M. Serologically indicated pneumococcal pneumonia in children: a population-based study in primary care settings. APMIS 2003; 111:945.
  44. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004; 9:109.
  45. Kurz H, Göpfrich H, Wabnegger L, Apfalter P. Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria. Pediatr Pulmonol 2009; 44:873.
  46. Carrillo-Marquez MA, Hulten KG, Hammerman W, et al. Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr Infect Dis J 2011; 30:545.
  47. Schwartz KL, Nourse C. Panton-Valentine leukocidin-associated Staphylococcus aureus necrotizing pneumonia in infants: a report of four cases and review of the literature. Eur J Pediatr 2012; 171:711.
  48. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894.
  49. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.
  50. Miller MA, Ben-Ami T, Daum RS. Bacterial pneumonia in neonates and older children. In: Pediatric Respiratory Medicine, Taussig LM, Landau LI (Eds), Mosby, St. Louis 1999. p.595.
  51. Rhedin S, Lindstrand A, Hjelmgren A, et al. Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study. Thorax 2015; 70:847.
  52. Cherry JD, Nadipuram S. Adenoviruses. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2014. p.1888.
  53. Juvén T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000; 19:293.
  54. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002; 346:429.
  55. Spichak TV, Yatsyshina SB, Кatosova LК, et al. Is the role of rhinoviruses as causative agents of pediatric community-acquired pneumonia over-estimated? Eur J Pediatr 2016; 175:1951.
  56. Heugel J, Martin ET, Kuypers J, Englund JA. Coronavirus-associated pneumonia in previously healthy children. Pediatr Infect Dis J 2007; 26:753.
  57. Memish ZA, Al-Tawfiq JA, Assiri A, et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J 2014; 33:904.
  58. Kahn JS, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J 2005; 24:S223.
  59. Longtin J, Bastien M, Gilca R, et al. Human bocavirus infections in hospitalized children and adults. Emerg Infect Dis 2008; 14:217.
  60. Abed Y, Boivin G. Human parechovirus types 1, 2 and 3 infections in Canada. Emerg Infect Dis 2006; 12:969.
  61. Don M, Söderlund-Venermo M, Valent F, et al. Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol 2010; 45:120.
  62. Schlaberg R, Ampofo K, Tardif KD, et al. Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia. J Infect Dis 2017; 216:688.
  63. Orvedahl A, Padhye A, Barton K, et al. Clinical Characterization of Children Presenting to the Hospital with Enterovirus D68 Infection During the 2014 Outbreak in St. Louis. Pediatr Infect Dis J 2016; 35:481.
  64. Bosis S, Esposito S. Enterovirus D68-Associated Community-Acquired Pneumonia in the Pediatric Age Group. Curr Infect Dis Rep 2017; 19:12.
  65. Al-Kaabi N, Solh Z, Pacheco S, et al. A Comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr Infect Dis J 2006; 25:1008.
  66. Esposito S, Bosis S, Cavagna R, et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis 2002; 35:1345.
  67. Greenberg D, Chiou CC, Famigilleti R, et al. Problem pathogens: paediatric legionellosis--implications for improved diagnosis. Lancet Infect Dis 2006; 6:529.
  68. Cunha BA, Burillo A, Bouza E. Legionnaires' disease. Lancet 2016; 387:376.
  69. Muldoon RL, Jaecker DL, Kiefer HK. Legionnaires' disease in children. Pediatrics 1981; 67:329.
  70. Andersen RD, Lauer BA, Fraser DW, et al. Infections with Legionella pneumophila in children. J Infect Dis 1981; 143:386.
  71. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002; 8:891.
  72. Lo MS, Lee GM, Gunawardane N, et al. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant 2013; 17:133.
  73. Arslan D, Danziger-Isakov L. Respiratory viral infections in pediatric solid organ and hematopoietic stem cell transplantation. Curr Infect Dis Rep 2012; 14:658.
  74. De Ceulaer K, McMullen KW, Maude GH, et al. Pneumonia in young children with homozygous sickle cell disease: risk and clinical features. Eur J Pediatr 1985; 144:255.
  75. Centers for Disease Control and Prevention. Histoplasmosis in a state where it is not known to be endemic--Montana, 2012-2013. MMWR Morb Mortal Wkly Rep 2013; 62:834.